The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Assessment of the role of α2‐adrenoceptor subtypes in the antinociceptive, sedative and hypothermic action of dexmedetomidine in transgenic mice
Open accessAbstract
The role of α 2‐adrenoceptor (AR) subtypes in the modulation of acute nociception, motor behaviour and body temperature, has been investigated by determining the activity of the α 2 AR selective agonist dexmedetomidine (Dex) in mice devoid of individual α 2 AR subtypes through either a point (α 2A) or null (α 2B/α 2C) mutation (‘knock‐out’). In a rodent model of acute thermal nociception, the mouse tail immersion test, Dex, in wild type (WT) control animals, produced a dose‐dependent increase in the threshold for tail withdrawal from a 52°C water bath with mean ED 50 values of 99.9±14.5 (α 2A), 94.6±17.8 (α 2B) and 116.0±17.1 (α 2C) μg kg−1, i.p. In comparison to the WT controls, Dex (100–1000 μg kg−1, i.p.), was completely ineffective as an antinociceptive agent in the tail immersion test in the α 2A AR D79N mutant animals. Conversely, in the α 2B AR and α 2C AR knock‐outs, Dex produced a dose‐dependent antinociceptive effect that was not significantly different from that observed in WT controls, with ED 50 values of 85.9±15.0 (P>0.05 vs WT control) and 226.0±62.7 (P>0.05 vs WT control) μg kg−1 i.p., respectively. Dex (10–300 μg kg−1, i.p.) produced a dose‐dependent reduction in spontaneous locomotor activity in the α 2A, α 2B and α 2C AR WT control animals with ED 50 values of 30.1±9.0, 23.5±7.1 and 32.3±4.6 μg kg−1, i.p., respectively. Again, Dex (100–1000 μg kg−1, i.p.) was ineffective at modulating motor behaviour in the α 2A AR D79N mutants. In the α 2B AR and α 2C AR knock‐out mice, Dex produced a dose‐dependent reduction in spontaneous locomotor activity with ED 50 values of 29.1±6.4 (P>0.05 vs WT control) and 57.5±11.3 (P>0.05 vs WT control) μg kg−1, respectively. Dex was also found to produce a dose‐dependent reduction in body temperature in the α 2A, α 2B and α 2C AR WT control mice with ED 50 values of 60.6±11.0, 16.2±2.5 and 47.2±9.1 μg kg−1, i.p., respectively. In the α 2A AR D79N mutants, Dex had no effect on body temperature at a dose (100 μg kg−1, i.p.) that produced a significant reduction (−6.2±0.5°C; P<0.01 vs vehicle) in temperature in WT controls. However, higher doses of Dex (300 and 1000 μg kg−1, i.p) produced a small, but statistically significant decrease in temperature corresponding to −1.7±0.4°C and −2.4±0.3°C (both P<0.01 vs vehicle), respectively. In the α 2B AR and α 2C AR knock‐out mice, Dex produced a dose‐dependent reduction in body temperature with ED 50 values of 28.4±4.8 (P>0.05 vs WT control) and 54.1±8.0 (P>0.05 vs WT control) μg kg−1, respectively. In conclusion, the data are consistent with the α 2A AR being the predominant subtype involved in the mediation of the antinociceptive, sedative and hypothermic actions of Dex. This profile would appear to indicate that an α 2A AR subtype selective analgesic will have a narrow therapeutic window, particularly following systemic administration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gene-targeting studies of mammalian behavior: is it the mutation or the background genotype?
Gerlai, R. (1996) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)20020-7 · Cited by 881 · cited 3×
“Consequently, the presence or absence of phenotypic abnormalities might be wrongly attributed to the null mutation when, instead, they may simply be the product of polymorphism in the genetic background (Gerlai, 1996).”
BackgroundInfluentialKobilka, B. K., Matsui, H., Kobilka, T. S., Yang-Feng, T. L., Francke, U., Caron, M. G., Lefkowitz, R. J., & Regan, J. W. (1987) · Science · doi:10.1126/science.2823383 · Cited by 787
Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia.
Maze, M., & Tranquilli, W. J. (1991) · PubMed · Cited by 700
Adrenergic Excitation of Cutaneous Pain Receptors Induced by Peripheral Nerve Injury
Sato, J., & Perl, E. R. (1991) · Science · doi:10.1126/science.2011742 · Cited by 595
Alpha-2 Adrenoceptor Agonists: Defining the Role in Clinical Anesthesia
Maze, M., & Tranquilli, W. (1991) · Anesthesiology · doi:10.1097/00000542-199103000-00029 · Cited by 537
Epidural clonidine analgesia for intractable cancer pain
Eisenach, J. C., DuPen, S., Dubois, M., Miguel, R., & Allin, D. (1995) · Pain · doi:10.1016/0304-3959(94)00209-w · Cited by 533
Gurd, A., & Wilson, R. (1972) · The Lancet · doi:10.1016/s0140-6736(72)91669-8 · Cited by 526
Central Hypotensive Effects of the α 2a -Adrenergic Receptor Subtype
MacMillan, L. B., Hein, L., Smith, M. S., Piascik, M. T., & Limbird, L. E. (1996) · Science · doi:10.1126/science.273.5276.801 · Cited by 489
Cardiovascular Regulation in Mice Lacking α 2 -Adrenergic Receptor Subtypes b and c
Link, R. E., Desai, K., Hein, L., Stevens, M. E., Chruscinski, A., Bernstein, D., Barsh, G. S., & Kobilka, B. K. (1996) · Science · doi:10.1126/science.273.5276.803 · Cited by 467
Self-citationNicholas, A. P., Pieribone, V., & Hökfelt, T. (1993) · Journal of Comparative Neurology · doi:10.1002/cne.903280409 · Cited by 459
Spinal cord pharmacology of adrenergic agonist-mediated antinociception.
Reddy, S. V., Maderdrut, J. L., & Yaksh, T. L. (1980) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)32101-4 · Cited by 434
Cloning and expression of a human kidney cDNA for an alpha 2-adrenergic receptor subtype.
Regan, J. W., Kobilka, T. S., Yang-Feng, T. L., Caron, M. G., Lefkowitz, R. J., & Kobilka, B. K. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.17.6301 · Cited by 434
Distribution of ?2C-adrenergic receptor-like immunoreactivity in the rat central nervous system
Rosin, D. L., Talley, E. M., Lee, A., Stornetta, R. L., Gaylinn, B. D., Guyenet, P. G., & Lynch, K. R. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960812)372:1<135::aid-cne9>3.0.co;2-4 · Cited by 353
Gene targeting — homing in on α2-adrenoceptor-subtype function
MacDonald, E., Kobilka, B. K., & Scheinin, M. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01063-8 · Cited by 310
Levine, J. D., Taiwo, Y. O., Collins, S. D., & Tam, J. K. (1986) · Nature · doi:10.1038/323158a0 · Cited by 279
Max, M. B., Schafer, S. C., Culnane, M., Dubner, R., & Gracely, R. H. (1988) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1988.44 · Cited by 247
Howe, J. R., Wang, J. Y., & Yaksh, T. L. (1983) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)33515-9 · Cited by 236
Gene targeting — homing in on α2-adrenoceptor-subtype function
MacDonald, E., Kobilka, B. K., & Scheinin, M. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90625-8 · Cited by 230
Distribution of ?2A-adrenergic receptor-like immunoreactivity in the rat central nervous system
Talley, E. M., Rosin, D. L., Lee, A., Guyenet, P. G., & Lynch, K. R. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960812)372:1<111::aid-cne8>3.0.co;2-6 · Cited by 223
Segal, I. S., Vickery, R. G., Walton, J. K., Doze, V. A., & Maze, M. (1988) · Anesthesiology · doi:10.1097/00000542-198812000-00004 · Cited by 219
Lanier, S. M., Downing, S., Duzic, E., & Homcy, C. J. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99248-3 · Cited by 218
Reversal of nerve ligation-induced allodynia by spinal alpha-2 adrenoceptor agonists.
Yaksh, T. L., Pogrel, J. W., Lee, Y. W., & Chaplan, S. R. (1995) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24308-7 · Cited by 218
Structure and function of alpha-adrenoceptors.
Ruffolo, R. R., Nichols, A. J., Stadel, J. M., & Hieble, J. P. (1991) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06670-0 · Cited by 208
Bylund, D. B., Blaxall, H. S., Iversen, L. J., Caron, M. G., Lefkowitz, R. J., & Lomasney, J. W. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08833-9 · Cited by 207
Reduction in Halothane Anesthetic Requirement by Clonidine, an Alpha-Adrenergic Agonist
Bloor, B. C., & Flacke, W. E. (1982) · Anesthesia & Analgesia · doi:10.1213/00000539-198209000-00005 · Cited by 173
Sallinen, J., Link, R. E., Haapalinna, A., Viitamaa, T., Kulatunga, M., Sjöholm, B., Macdonald, E., Pelto-Huikko, M., Leino, T., Barsh, G. S., et al. (1997) · Molecular Pharmacology · doi:10.1124/mol.51.1.36 · Cited by 172
Self-citationTakano, Y., & Yaksh, T. L. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11102-6 · Cited by 169
Molecular characterization of a rat alpha 2B-adrenergic receptor.
Zeng, D. W., Harrison, J. K., D'Angelo, D. D., Barber, C. M., Tucker, A. L., Lu, Z. H., & Lynch, K. R. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.8.3102 · Cited by 161
Continuous intrathecal hydromorphone and clonidine for intractable cancer pain
Coombs, D. W., Saunders, R. L., Fratkin, J. D., Jensen, L. E., & Murphy, C. A. (1986) · Journal of neurosurgery · doi:10.3171/jns.1986.64.6.0890 · Cited by 151
α 2-Adrenergic receptor subtypes in rat dorsal root and superior cervical ganglion neurons
Gold, M. S., Dastmalchi, S., & Levine, J. D. (1997) · Pain · doi:10.1016/s0304-3959(96)03218-6 · Cited by 136
Millan, M. J., Bervoets, K., Rivet, J., Widdowson, P. S., Renouard-Try, A., Marouille-Girardon, S. L., & Gobert, A. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22564-2 · Cited by 130
Alpha2‐adrenergic agents in anaesthesia
Aantaa, R., & Scheinin, M. (1993) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1993.tb03743.x · Cited by 126
Peripheral nociceptive effects of α2-adrenergic receptor agonists in the rat
Khasar, S. G., Green, P. G., Chou, B., & Levine, J. D. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00562-j · Cited by 120
POSTOPERATIVE ANALGESIA WITH EXTRADURAL CLONIDINE
Bonnet, F. J., Boico, O., Rostaing, S., et al. (1989) · British Journal of Anaesthesia · doi:10.1093/bja/63.4.465 · Cited by 101
Lee, Y.-W., & Yaksh, T. L. (1995) · Anesthesiology · doi:10.1097/00000542-199503000-00016 · Cited by 75
Chalberg, S. C., Duda, T., Rhine, J., & Sharma, R. (1990) · Molecular and Cellular Biochemistry · doi:10.1007/bf00221058 · Cited by 74
Diverse tissue expression of rat alpha 2-adrenergic receptor genes.
Handy, D. E., Flordellis, C. S., Bogdanova, N. N., Bresnahan, M. R., & Gavras, H. P. (1993) · Hypertension · doi:10.1161/01.hyp.21.6.861 · Cited by 67
Characterization of distinct phospholipases mediating bradykinin and noradrenaline hyperalgesia
Taiwo, Y. O., Heller, P. H., & Levine, J. D. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90288-f · Cited by 60
Evidence that an α2A-adrenoceptor subtype mediates antinociception in mice
Millan, M. J. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90059-d · Cited by 56
Luttinger, D. A. (1985) · Journal of Pharmacological Methods · doi:10.1016/0160-5402(85)90017-8 · Cited by 48
Codd, E. E., Press, J. B., & Raffa, R. B. (1995) · Life Sciences · doi:10.1016/0024-3205(94)00415-o · Cited by 41
Alpha-2 agonists and analgesia
Eisenach, J. C. (1994) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.3.10.1005 · Cited by 27
Lee, E., & Donovan, K. L. (1995) · Anesthesiology · doi:10.1097/00000542-199501000-00036 · Cited by 21
Cited by
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
The induction of pain: an integrative review
Millan, M. J. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00048-3 · Cited by 1,774
Dexmedetomidine: A Novel Sedative-Analgesic Agent
Gertler, R., Brown, H. C., Mitchell, D. H., & Silvius, E. N. (2001) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2001.11927725 · Cited by 856
Pertovaara, A. (2006) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2006.08.001 · Cited by 597
Bhana, N., Goa, K. L., & McClellan, K. J. (2000) · Drugs · doi:10.2165/00003495-200059020-00012 · Cited by 597
Metadata
- Authors
- Hunter, J. C., Fontana, D. J., Hedley, L. R., Jasper, J. R., Lewis, R., Link, R. E., Secchi, R., Sutton, J., & Eglen, R. M.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 1997-12
- Volume
- 122
- Issue
- 7
- Pages
- 1339-1344
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2023358654
- Cited by
- 294
- References
- 43
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.